Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Calgary

$37,000.00

Statistical inference for epidemic models accounting for population heterogeneity: computational efficiency & model development

EF 2024-25

Résumé
At the beginning of the COVID-19 pandemic, disease modellers very quickly put together fairly complex epidemic models (e.g., incorporating age structure, effect of movement restrictions, etc.) to make forecasts/projections. This was done, as is typical, in what a statistician would consider a fairly ad hoc manner, obtaining estimates for the various parameters (e.g., transmission rates, infectious & incubation periods, mixing rates) from different studies and/or using non-linear least squares estimation. To try and allow for uncertainty in these estimates, hopefully a sensitivity analysis would be carried out. In those circumstances, I do not criticize this approach -- and indeed, my group carried out such work; it was really the only way to get these models up and running quickly. However, from a statistical point of view, such an approach to building models has well known dangers, lacking reliable and rigorous quantification of uncertainty, or the testing of the significance of risk factors, etc., in a statistically coherent framework. A Bayesian approach to building these models would seem ideal. Such an approach allows for the uncertainty quantification regarding parameters and model, incorporation of uncertainty regarding the data, and incorporation of prior knowledge from different sources, all in a structured and transparent way. However, in emerging epidemics and pandemics, disease forecast models are not typically built in this way. Why is this? In the main, it is because the statistical technology (e.g., methodology and software) to fit such models quickly to data (especially if very messy), is not readily available. So, in early 2019, the time taken to code up the required models, and run the computational algorithms used to carry out the Bayesian analysis, would have been prohibitive. Unfortunately, this problem is common across a wide variety of models we might want to fit the data on human, animal and crop disease. My focus here is on so-called `individual-based' or `individual-level' disease models. These models allow for complex heterogeneities in the population, such as spatial location, vaccination status, and mixing between different groups, to be accounted for. They are therefore more realistic than simple `classical' disease models that assume the population is homogeneous, but the computational problems mentioned are even more acute. Thus, the goal of this research program is to develop: 1. individual-level disease model classes which can more realistically mimic real life (e.g., incorporating population behavioural change); 2.  computational technology to fit these models to observed data quickly in a Bayesian framework; and, 3. make such developments more widely available through the development of easy-to-use software. These developments can then be used to further our understanding of infectious diseases, and through this, our ability to control them, helping save lives and alleviating severe economic outcomes.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2022-03292
Name nom
Deardon, Rob
Department département
Mathematics and Statistics - Mathematics and Statistics
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2022
Award amount
37000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1508
Committee name en
Mathematics and Statistics
Committee name fr
Mathématiques et statistique
Area of application code
405
Area of application group en
Environment
Area of application group fr
Environnement
Area of application en
Modelling and mathematical simulation of natural processes
Area of application fr
Modélisation et simulation mathématique des processus naturels
Research subject code
3000
Research subject group en
Statistics and probability
Research subject group fr
Statistique et probabilité
Research subject en
Statistics and probability
Research subject fr
Statistique et probabilité
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Statistical inference for epidemic models accounting for population heterogeneity: computational efficiency & model development
Keywords
epidemic models; inference; bayesian & computational statistics; spatial disease models; network-based disease models; behavioural change disease models; approximate inference; gaussian process emulation; geostatistical models
Application summary
At the beginning of the COVID-19 pandemic, disease modellers very quickly put together fairly complex epidemic models (e.g., incorporating age structure, effect of movement restrictions, etc.) to make forecasts/projections. This was done, as is typical, in what a statistician would consider a fairly ad hoc manner, obtaining estimates for the various parameters (e.g., transmission rates, infectious & incubation periods, mixing rates) from different studies and/or using non-linear least squares estimation. To try and allow for uncertainty in these estimates, hopefully a sensitivity analysis would be carried out. In those circumstances, I do not criticize this approach -- and indeed, my group carried out such work; it was really the only way to get these models up and running quickly. However, from a statistical point of view, such an approach to building models has well known dangers, lacking reliable and rigorous quantification of uncertainty, or the testing of the significance of risk factors, etc., in a statistically coherent framework. A Bayesian approach to building these models would seem ideal. Such an approach allows for the uncertainty quantification regarding parameters and model, incorporation of uncertainty regarding the data, and incorporation of prior knowledge from different sources, all in a structured and transparent way. However, in emerging epidemics and pandemics, disease forecast models are not typically built in this way. Why is this? In the main, it is because the statistical technology (e.g., methodology and software) to fit such models quickly to data (especially if very messy), is not readily available. So, in early 2019, the time taken to code up the required models, and run the computational algorithms used to carry out the Bayesian analysis, would have been prohibitive. Unfortunately, this problem is common across a wide variety of models we might want to fit the data on human, animal and crop disease. My focus here is on so-called `individual-based' or `individual-level' disease models. These models allow for complex heterogeneities in the population, such as spatial location, vaccination status, and mixing between different groups, to be accounted for. They are therefore more realistic than simple `classical' disease models that assume the population is homogeneous, but the computational problems mentioned are even more acute. Thus, the goal of this research program is to develop: 1. individual-level disease model classes which can more realistically mimic real life (e.g., incorporating population behavioural change); 2.  computational technology to fit these models to observed data quickly in a Bayesian framework; and, 3. make such developments more widely available through the development of easy-to-use software. These developments can then be used to further our understanding of infectious diseases, and through this, our ability to control them, helping save lives and alleviating severe economic outcomes.